Optic nerve glioma MRI: Difference between revisions

	Optic nerve glioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Optic nerve glioma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Optic nerve glioma MRI On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Optic nerve glioma MRI All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Optic nerve glioma MRI
CDC on Optic nerve glioma MRI
Optic nerve glioma MRI in the news
Blogs on Optic nerve glioma MRI
Directions to Hospitals Treating Optic nerve glioma
Risk calculators and risk factors for Optic nerve glioma MRI

Revision as of 20:36, 24 September 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [4]


MRI component	Features

T1	enlargement is often isointense to hypointense compared to the contralateral side
T2	hyperintense centrally low signal at the periphery representing the dura
T1 C+ (Gd)	enhancement is variable

↑ Image courtesy of Dr Frank Gaillard. Radiopaedia (original file [1]).[http://radiopaedia.org/licence Creative Commons BY-SA-NC
↑ Image courtesy of Dr Frank Gaillard. Radiopaedia (original file [2]).[http://radiopaedia.org/licence Creative Commons BY-SA-NC
↑ Image courtesy of Dr Frank Gaillard. Radiopaedia (original file [3]).[http://radiopaedia.org/licence Creative Commons BY-SA-NC

@@ Line 4: / Line 4: @@
 ==Overview==
 ==MRI==
-MRI is the modality of choice to diagnosis and assessment of the posterior extent of the tumour.
-T1: enlargement, often iso to hypointense compared to the contralateral side
-T1 C+ (Gd): enhancement is variable
-T2
-hyperintense centrally
-low signal at the periphery representing the dura
 {| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center
 |valign=top|